Harvard Bioscience Market Cap 2010-2023 | HBIO
Harvard Bioscience market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Harvard Bioscience market cap as of April 26, 2024 is $0.15B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.155B | $0.112B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mettler-Toledo (MTD) | United States | $26.369B | 32.38 |
| Bruker (BRKR) | United States | $11.713B | 31.24 |
| Kewaunee Scientific (KEQU) | United States | $0.102B | 12.06 |